FDA 510(k) Consultants: How to Choose, Vet, and Work with a Clearance Partner
How to select, evaluate, and engage an FDA 510(k) consultant — fees by device complexity, engagement models, red flags, due diligence checklist, and when hiring one makes financial sense.
Why Companies Hire 510(k) Consultants
In FY 2025, the FDA received approximately 3,700 510(k) submissions and cleared roughly 3,200. About 35% of submissions received at least one round of Additional Information (AI) requests — meaning they were incomplete, unclear, or lacked critical data. Each AI cycle adds 3–6 months to the clearance timeline and consumes internal resources responding to FDA deficiencies.
A 510(k) consultant does not guarantee clearance, but the right one reduces the probability of AI requests, shortens the total review cycle, and helps you avoid mistakes that are expensive to fix after submission. The wrong one wastes time and money.
This article covers when hiring a 510(k) consultant makes sense, what they cost, how to evaluate candidates, and what to expect from the engagement. It focuses specifically on 510(k) consultants — not general regulatory consultants, not PMA consultants, and not ISO 13485 implementation consultants. If you need broader guidance on choosing a regulatory consultant, see our general consultant selection guide.
When to Hire a 510(k) Consultant
Not every company needs external help for a 510(k). Here is when it makes the most financial sense.
You Should Strongly Consider Hiring One If
This is your first 510(k). The learning curve is steep. Your first submission will take 2–3× longer than subsequent ones if you handle it internally, and the probability of an AI request is significantly higher for first-time submitters.
Your device involves software, cybersecurity, or AI/ML. Since October 2023, the FDA has required SBOM documentation and cybersecurity risk analysis for cyber devices under Section 524B of the FD&C Act, with enforcement tightened through the February 2026 QMSR-aligned cybersecurity guidance update. For AI-enabled devices, a predetermined change control plan (PCCP) is expected. These requirements are technically complex and a common source of AI requests.
Your predicate strategy is not straightforward. If your device is a multi-component system, a combination product, or has features that differ significantly from the predicate, the predicate justification requires experienced strategy work.
You are a non-US manufacturer. Foreign manufacturers face additional requirements (US Agent appointment, eSTAR submission formatting, English-language documentation) that a US-experienced consultant handles routinely.
You need to clear multiple devices quickly. If you are building a product line and need to clear 3–5 devices within 12–18 months, a consultant who has done this before will be faster than building the capability internally.
You May Be Able to Handle It Internally If
- You have an experienced regulatory affairs professional on staff who has prepared and submitted at least 5–10 successful 510(k)s in your device category
- Your device is a straightforward Class II device with a well-established predicate and no software or connectivity features
- You have strong technical writing capabilities and a robust design history file (DHF) that is already well-organized
- You have the bandwidth — regulatory staff who can dedicate 60–80% of their time to the submission for 3–6 months without neglecting other obligations
What a 510(k) Consultant Actually Does
The scope of work varies by engagement model, but a full-service 510(k) consultant typically handles these activities:
Pre-Submission Phase
| Activity | Description |
|---|---|
| Classification confirmation | Verifies your device classification, product code, and regulation number against the FDA product classification database |
| Predicate device search and selection | Identifies the optimal predicate device(s) based on intended use, technological characteristics, and regulatory history |
| Regulatory pathway assessment | Confirms 510(k) is the correct pathway (vs. De Novo, PMA, or exemption) and identifies any special controls, guidance documents, or classification panels that apply |
| Gap analysis | Reviews your existing design documentation (DHF, risk analysis, test reports, labeling) against FDA expectations for your device type and identifies missing data |
| Pre-submission (Q-Submission) strategy | Determines whether a pre-submission meeting with FDA is advisable and, if so, prepares the briefing package and manages the meeting logistics |
| Testing plan | Identifies what performance testing, biocompatibility testing, EMC/electrical safety testing, and/or software validation is needed based on your device type and predicate |
Submission Preparation Phase
| Activity | Description |
|---|---|
| eSTAR compilation | Assembles the submission using the FDA's eSTAR template, which has been mandatory for all 510(k) submissions since October 2023 |
| Technical file writing | Drafts the substantial equivalence discussion, device description, performance data summaries, and comparison tables |
| Labeling review | Reviews proposed labeling for compliance with 21 CFR Part 801 and any device-specific requirements |
| Risk analysis integration | Ensures the risk management file (ISO 14971) is properly referenced and that risk control measures are traced to verification evidence |
| Software documentation | Prepares or reviews the Software Bill of Materials (SBOM), cybersecurity documentation, and IEC 62304 software lifecycle documentation if applicable |
| Final review and quality check | Conducts a comprehensive review of the complete submission package for consistency, completeness, and compliance with FDA formatting requirements |
Post-Submission Phase
| Activity | Description |
|---|---|
| AI request response | If FDA issues an Additional Information request, the consultant helps prepare a complete and responsive reply within the 180-day deadline |
| Interactive review management | Manages communications with the FDA lead reviewer during the interactive review period |
| Post-clearance support | Advises on establishment registration, device listing, labeling finalization, and any post-market obligations triggered by clearance conditions |
510(k) Consultant Fees: What You Will Pay
Pricing varies significantly based on device complexity, the consultant's experience, and the engagement model. The following ranges are based on publicly available pricing from consulting firms and industry benchmarks as of mid-2026.
By Device Complexity
| Device Complexity | Typical Consultant Fee (Full Service) | Typical Timeline |
|---|---|---|
| Simple Class II (non-powered instruments, basic disposables, non-sterile devices) | $8,000–$18,000 | 4–6 months |
| Moderate complexity (powered devices, devices with some electronics, moderate-risk IVDs) | $18,000–$40,000 | 6–10 months |
| High complexity (active implantables, complex IVDs, devices with software/AI) | $40,000–$85,000+ | 10–18 months |
| SaMD and AI-enabled devices | $30,000–$70,000 | 8–14 months |
Source: Consultant pricing data compiled from TRACC Global, Cruxi, I3CGlobal, and Elexes published fee ranges, 2025–2026. Fees are for consulting services only; FDA user fees, testing costs, and other third-party costs are additional.
By Engagement Model
| Model | Typical Fee Range | Best For |
|---|---|---|
| Solo consultant (hourly) | $150–$300/hour | Specific tasks (e.g., predicate search, submission review), not full submission management |
| Solo consultant (fixed fee) | $15,000–$40,000 | Simple to moderate devices where you need full submission support |
| Consulting firm (fixed fee) | $30,000–$80,000+ | Moderate to complex devices; firm provides multiple specialists |
| Law firm | $50,000–$150,000+ | Complex cases involving enforcement history, legal risk, or novel regulatory questions |
| CRO / full-service | $40,000–$100,000+ | Projects requiring clinical support, testing coordination, and project management |
| Hybrid AI + consultant | $5,000–$20,000 | Lower-cost model where AI structures the submission and the consultant focuses on strategy and review |
Additional Costs Beyond Consulting Fees
| Cost Category | Typical Range |
|---|---|
| FDA 510(k) user fee (FY 2026 standard) | $26,067 |
| FDA 510(k) user fee (FY 2026 small business) | $6,517 (requires SBD certification) |
| FDA establishment registration (FY 2026) | $11,423 (per establishment, not per device) |
| Performance/bench testing | $20,000–$100,000+ (depends on device type) |
| Biocompatibility testing (ISO 10993) | $10,000–$50,000+ |
| EMC/electrical safety testing (IEC 60601) | $15,000–$40,000 |
| Software V&V documentation | $10,000–$30,000 (if outsourced) |
| US Agent (for foreign manufacturers) | $1,500–$5,000/year |
Source: FDA fee schedule for FY 2026 (effective October 1, 2025). Testing cost ranges are industry estimates and vary significantly by device type, lab, and testing scope.
Total Project Cost Examples
| Scenario | Consultant Fee | FDA Fees | Testing | Total |
|---|---|---|---|---|
| Simple Class II, small business | $12,000 | $6,517 + $11,423 | $25,000 | ~$55,000 |
| Moderate complexity, standard fee | $30,000 | $26,067 + $11,423 | $60,000 | ~$127,000 |
| Complex device with software, standard fee | $65,000 | $26,067 + $11,423 | $90,000 | ~$192,000 |
These are representative ranges. Your actual costs depend on the device, the consultant, the testing required, and your small business status.
The Cost-Benefit Case
About 35% of 510(k) submissions receive at least one Additional Information request from the FDA. Each AI cycle adds 3–6 months and requires significant internal resources to respond. A $30,000–$50,000 consulting engagement that prevents even one AI cycle can save $50,000–$100,000 in re-testing, resubmission, and delayed market entry costs. The 35% AI rate is not uniformly distributed — first-time submitters and companies without experienced regulatory staff are disproportionately represented.
How to Evaluate a 510(k) Consultant
Essential Qualifications to Verify
510(k) track record. Ask how many 510(k)s they have prepared or managed in the past 3 years, and how many were cleared on the first cycle without an AI request. A first-cycle clearance rate of 85–90% or higher is a strong indicator.
Device category experience. A consultant who has cleared 20 orthopedic devices but zero IVDs is not the right choice for your IVD. Ask for specific experience in your device's product code and classification panel.
Current FDA knowledge. The regulatory landscape changes rapidly. Confirm the consultant is current on eSTAR requirements (mandatory since October 2023), QMSR (effective February 2026), cybersecurity documentation expectations, and any device-specific guidance documents that apply to your product.
References. Ask for 2–3 references from companies that have used their 510(k) services in the past 12–18 months. Specifically ask about: communication quality, adherence to timeline and budget, and how they handled AI requests.
Team composition. For consulting firms, ask who specifically will be working on your project. The person selling you the service is not always the person doing the work. Request the lead consultant's credentials and experience.
Due Diligence Checklist
Before signing an engagement letter, confirm the following:
- The consultant has cleared at least 3–5 510(k)s in your specific device category
- They can provide references from companies similar to yours (similar size, device type, and complexity)
- They have current knowledge of eSTAR submission format and requirements
- They understand the software/cybersecurity documentation requirements that apply to your device
- They have a clear scope of work with defined deliverables and milestones
- Their fee structure is transparent (fixed fee vs. hourly, what is included, what is extra)
- They carry professional liability insurance
- There is no conflict of interest (they are not simultaneously advising a competitor on a similar device)
- The engagement letter specifies who owns the intellectual property in the submission documents
- They have a written confidentiality agreement / NDA in place
Red Flags
Guaranteeing clearance. No ethical consultant will guarantee FDA clearance. The FDA makes the decision, and many factors outside the consultant's control affect the outcome. A consultant who promises clearance is either inexperienced or dishonest.
No device-specific experience. If a consultant claims they can handle any device type, they may be a generalist who lacks the depth needed for your specific product. 510(k) preparation is not a generic skill — device-specific technical knowledge matters.
Vague proposals. A proposal that does not list specific deliverables, milestones, and a timeline is a warning sign. You should know exactly what you are getting for the fee.
No discussion of predicate strategy. The predicate device selection is the single most important strategic decision in a 510(k). If a consultant does not want to discuss predicate strategy during the evaluation phase, that is a problem.
Rates that seem too low. A consultant offering full 510(k) preparation for $3,000–$5,000 is either not providing full service or is desperate for work. Neither is good. Compare their proposal against the fee ranges above.
Unwillingness to put scope in writing. If the consultant resists documenting the scope, deliverables, and fee in a formal agreement, move on.
Practical Contract and Payment Tips
Payment Milestones
For fixed-fee engagements, a common and well-balanced payment schedule is:
- 30% at signing — confirms commitment and funds initial work (classification, predicate search, gap analysis)
- 40% at first draft — aligns payment with the bulk of the technical work (eSTAR compilation, technical writing)
- 30% at FDA submission — ties the final payment to the completed deliverable
Avoid paying 100% upfront. A consultant who demands full payment before starting work has no financial incentive to perform.
NTE Caps for Hourly Engagements
If you engage a consultant on an hourly basis, insist on a Not to Exceed (NTE) cap — a monthly maximum spend that cannot be exceeded without your written approval. For example:
"Consultant rate: $250/hour. Total monthly charges shall not exceed $15,000 without prior written approval from Client."
This protects you from billings that escalate beyond the project budget while still allowing flexibility for scope changes you approve.
Scope Change Provisions
Include a clause in the engagement letter that defines how scope changes are handled:
"Any services requested by Client that fall outside the scope of this Statement of Work shall require a written change order signed by both parties, including a description of the additional work, revised timeline, and additional fee."
This prevents disputes about whether work was in-scope or out-of-scope and ensures both parties agree to any cost increases before the work is performed.
Strategy-Only Engagement
The consultant provides regulatory strategy, predicate selection, and a gap analysis, but your internal team prepares the submission. Typical fee: $5,000–$15,000. Best for companies with strong technical writing capabilities and an experienced regulatory team that just needs strategic guidance.
Full-Service Engagement
The consultant manages the entire process from classification to clearance, including eSTAR compilation, technical writing, and AI response management. Typical fee: $15,000–$85,000+ depending on complexity. Best for companies without dedicated regulatory staff or those pursuing their first 510(k).
Hourly Advisory
The consultant is available on an hourly basis to answer questions, review draft sections, and provide guidance as your internal team prepares the submission. Typical rate: $150–$300/hour. Best for experienced regulatory teams that need targeted expertise on specific issues.
Submission Review Only
The consultant conducts a final review of your completed submission package before you submit to FDA. Typical fee: $3,000–$8,000. Best for experienced teams that want a second set of eyes on the package. This is the lowest-cost option but provides the least support.
The Consultant Engagement Timeline
A typical full-service 510(k) engagement follows this sequence:
| Phase | Timeline | Key Activities |
|---|---|---|
| 1. Scoping and proposal | Weeks 1–2 | Classification review, predicate search, gap analysis, proposal and contract |
| 2. Strategy and planning | Weeks 3–6 | Predicate selection, testing plan, pre-submission decision, project plan |
| 3. Documentation preparation | Weeks 7–18 | Technical file drafting, labeling, risk analysis, software documentation |
| 4. Testing coordination | Weeks 7–22 (overlapping) | Managing external test labs, reviewing test reports, addressing failures |
| 5. Submission compilation | Weeks 16–22 | Assembling eSTAR package, final review, quality check |
| 6. FDA submission | Week 22–23 | Submitting to FDA, receiving acknowledgement |
| 7. FDA review | Weeks 23–35 (90-day review) | Managing interactive review, responding to any FDA questions |
| 8. AI response (if needed) | Weeks 30–40 | Preparing Additional Information response, resubmitting |
| 9. Clearance | Weeks 35–45 | Receiving clearance letter, advising on post-market obligations |
The total timeline from engagement to clearance typically ranges from 4 to 18 months depending on device complexity and whether an AI request is received.
Foreign Manufacturer Considerations
Non-US manufacturers face additional requirements that a US-based or internationally experienced 510(k) consultant can help navigate:
US Agent appointment. Every foreign manufacturer must designate a US Agent before submitting a 510(k). Some consultants provide this service; others do not.
eSTAR formatting. The mandatory eSTAR template is in English and requires data in specific FDA formats. Consultants experienced with foreign submissions know how to translate and format documentation to meet FDA expectations.
Establishment registration. Foreign establishments must register with the FDA and list their devices. This is separate from the 510(k) submission but must be completed before or shortly after clearance.
Testing lab coordination. Test data from non-US laboratories may require additional documentation or explanation. A consultant with experience managing international test labs can help ensure test reports meet FDA expectations.
Alternatives to Hiring a 510(k) Consultant
If you decide not to hire a consultant, consider these alternatives:
Build Internal Capability
Hire or designate a regulatory affairs professional with direct 510(k) experience. The investment in a full-time employee ($80,000–$150,000/year total compensation for a mid-level RA professional in the US, per industry data) pays for itself after 2–3 submissions if you have ongoing regulatory needs.
Use AI-Assisted Tools
Several platforms now offer AI-assisted 510(k) preparation tools that structure the submission, identify gaps, and draft sections. These tools typically cost $5,000–$20,000 and can reduce the time required for submission preparation by 40–60%, though they do not replace experienced regulatory judgment.
Engage a Consultant for Strategy Only
Hire a consultant for the first 4–6 weeks to establish the predicate strategy, identify gaps, and create a project plan, then execute the submission internally. This gives you the benefit of expert strategy at a fraction of the full-service cost.
Frequently Asked Questions
How much does a 510(k) consultant cost?
Full-service 510(k) consulting fees range from $8,000 for simple devices to $85,000+ for complex devices with software or AI components. Hourly rates for individual consultants typically range from $150 to $300 per hour. These fees are for consulting services only and do not include FDA user fees ($26,067 standard or $6,517 small business for FY 2026), testing costs, or other third-party expenses.
When should I hire a 510(k) consultant?
Engage a consultant as early as possible — ideally during the design input phase, before you have committed to a specific design or testing plan. The earlier a consultant is involved, the more value they provide in avoiding costly design or documentation decisions that create problems during FDA review.
Can a consultant guarantee 510(k) clearance?
No ethical consultant will guarantee clearance. The FDA makes the final decision. A good consultant significantly increases the probability of first-cycle clearance (typically 85–90% for experienced firms vs. ~65% industry average), but no one can guarantee an outcome.
What is the difference between a 510(k) consultant and a regulatory affairs consultant?
A 510(k) consultant specializes in premarket notification submissions. A regulatory affairs consultant may have broader capabilities including PMA, De Novo, EU MDR CE marking, ISO 13485 implementation, and post-market compliance. Some professionals offer both; others specialize. For a 510(k) submission, you want someone with demonstrated 510(k)-specific experience, not just general regulatory knowledge.
Do I need a consultant if I have already submitted a 510(k) before?
Not necessarily. If your internal team has successfully submitted and obtained clearance for similar devices, you may be able to handle subsequent submissions without external help. However, if the new device involves a different product code, new technology, software, or a different FDA review division, a consultant's experience can still be valuable.
How do I verify a consultant's track record?
Ask for the number of 510(k)s they have cleared in the past 3 years, specifically in your device category. Request 2–3 client references. You can also search the FDA's 510(k) database for submissions prepared by the consultant's firm (though the database does not always identify the consultant).